Abstract:
Two new manganese complexes of NSAID mefenamic acid (Hmef) with heterocyclic diimines, 4,4'-diethoxy 2,2'-bipyridine (DEB) and 4,4'-dimethyl 2,2'-bipyridine (DMB) were synthesized. DEB crystallised in triclinic P sub(1) space group, exhibiting a 2-D network. MM1 crystallised in triclinic P1 space group, with mef sup(2-) adopting monodentate and bidentate chelate modes to Mn, owing to its flexibility and DEB with bidentate chelation. The interplay of O-H...O, N-H...O, and C-H...O interactions stabilised the overall lattice of MM1. MM2 crystallized in triclinic P sub(1) space group with mef sup(2-) and DMB adopting diverse coordination modes to Mn and the Pi-Pi stacking and hydrogen bonding interactions gave rise to a parallel alignment of Mn units when extended along b axis. The thermalprofiles of MM1 and MM2 corroborated with the crystal structure, evidencing the loss of solvent between RT- 127 degrees C, followed by ligand decomposition. XPS analysis of MM1 and MM2 validated the presence of Mn in + 2 oxidationstate, thereby confirming ligand composition. The magnetic susceptibility values for MM1 and MM2 increased with decreasing temperature, suggesting paramagnetic nature of Mn(II) in both the compounds. Interestingly, MM1 and MM2 exhibited 15.67 plus-minus 0.21 percent and 19.17 plus-minus 0.10 percent cell viability, respectively, of HepG2 cancerous cells at 100 Mu g/mL and possessed DNA cleavage activity, indicating their role in biomedical applications.
